Unique Cell Adhesion and Invasion Properties of Yersinia enterocolitica O:3, the Most Frequent Cause of Human Yersiniosis by Uliczka, Frank et al.
Unique Cell Adhesion and Invasion Properties of Yersinia
enterocolitica O:3, the Most Frequent Cause of Human
Yersiniosis
Frank Uliczka
1,2, Fabio Pisano
1, Julia Schaake
1,2, Tatjana Stolz
1,2, Manfred Rohde
3, Angelika Fruth
4,
Eckhard Strauch
5, Mikael Skurnik
6, Julia Batzilla
7, Alexander Rakin
7,J u ¨rgen Heesemann
7, Petra
Dersch
1,2*
1Department of Molecular Infection Biology, Helmholtz-Zentrum fu ¨r Infektionsforschung, Braunschweig, Germany, 2Institut fu ¨r Mikrobiologie, Technische Universita ¨t
Braunschweig, Braunschweig, Germany, 3Department of Medical Microbiology, Helmholtz-Zentrum fu ¨r Infektionsforschung, Braunschweig, Germany, 4Robert Koch-
Institut, Wernigerode, Germany, 5Bundesinstitut fu ¨r Risikoforschung, Berlin, Germany, 6Department of Bacteriology and Immunology, The Haartman Institute, University
of Helsinki and Helsinki University Central Hospital Laboratory Diagnostics, Helsinki, Finland, 7Max von Pettenkofer Institut, Ludwigs-Maximilians-Universita ¨t, Mu ¨nchen,
Germany
Abstract
Many enteric pathogens are equipped with multiple cell adhesion factors which are important for host tissue colonization
and virulence. Y. enterocolitica, a common food-borne pathogen with invasive properties, uses the surface proteins invasin
and YadA for host cell binding and entry. In this study, we demonstrate unique cell adhesion and invasion properties of Y.
enterocolitica serotype O:3 strains, the most frequent cause of human yersiniosis, and show that these differences are mainly
attributable to variations affecting the function and expression of invasin in response to temperature. In contrast to other
enteric Yersinia strains, invasin production in O:3 strains is constitutive and largely enhanced compared to other Y.
enterocolitica serotypes, in which invA expression is temperature-regulated and significantly reduced at 37uC. Increase of
invasin levels is caused by (i) an IS1667 insertion into the invA promoter region, which includes an additional promoter and
RovA and H-NS binding sites, and (ii) a P98S substitution in the invA activator protein RovA rendering the regulator less
susceptible to proteolysis. Both variations were shown to influence bacterial colonization in a murine infection model.
Furthermore, we found that co-expression of YadA and down-regulation of the O-antigen at 37uC is required to allow
efficient internalization by the InvA protein. We conclude that even small variations in the expression of virulence factors
can provoke a major difference in the virulence properties of closely related pathogens which may confer better survival or
a higher pathogenic potential in a certain host or host environment.
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Introduction
Yersinia enterocolitica is a common gram-negative zoonotic pathogen
that is able to grow in the environment and cause enteric diseases
(Yersiniosis), ranging from enteritis, severe diarrhea, mesenteric
lymphadenitis, hepatic or splenic abscesses to postinfectious extrain-
testinal sequelae such as reactive arthritis and erythema nodosum [1].
Infection by Y. enterocolitica is usually initiated through uptake of
contaminated food or water. Following ingestion, the bacteria first
colonize the lumen and transmigrate through antigen-sampling M
cells across the epithelial lining of the small intestine, resulting in the
colonization of the underlying lymphoid tissues (Peyer’s patches)
[2,3]. Subsequently, Y. enterocolitica can spread via the lymph and/or
blood into the mesenteric lymph nodes or to extraintestinal sites such
as liver and spleen [4,5,6]. Alternatively, the bacteria may bypass
colonization of the Peyer’s patches and spread directly from the
intestine to the systemic tissues, similar to what has been observed for
enteropathogenic Yersinia pseudotuberculosis [7,8].
Adhesion, invasion and survival in deeper tissues depend on
several Yersinia virulence factors encoded on the Yersinia
chromosome or the 65–70 kb virulence plasmid (pYV) [9]. Y.
enterocolitica produces at least three invasion factors, invasin, Ail
(attachment-invasion locus), and YadA (Yersinia adhesin A)
which were shown to promote adherence to and invasion into
mammalian cells [10,11,12]. Invasin, the primary invasion
factor, binds with high affinity to beta 1 chain integrin
receptors found on the surface of M cells but not on the apical
side of brush border cells, and mediates efficient and rapid
internalization into host cells [13,14]. As invasin is strongly
expressed at environmental temperature but only weakly at
37uC, it is assumed to support initial colonization and survival
of host tissues during the very early stages of an infection
[15,16,17]. Recent studies showed that the dimeric winged-
helix transcriptional regulator RovA controls transcription of
the invasin gene (invA) in response to temperature. For this
purpose, RovA uses an in-built thermosensor to control its
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degradation by ATP-dependent proteases [18].
After the initiation of the infection, the YadA and Ail proteins
seem to be the predominant adhesins in infected tissues. Both
virulence factors mediate serum resistance and promote tight
adherence to extracellular matrix proteins, such as fibronectin
and/or collagen, but their contribution to bacterial uptake is
relatively small [19,20,21,22,23,24,25]. The yadA gene is located
on pYV and its expression, together with the plasmid-encoded
type III secretion system (Ysc proteins) and the antiphagocytic
effector proteins (Yops) is controlled by the VirF(LcrF) activator.
VirF-dependent induction of yadA, yop and ysc expression occurs
exclusively at 37uC [26,27]. Ail is also predominantly expressed at
37uC, and regulated by pH and oxygen content, but the control
mechanisms are still unclear [24].
Besides the classical pathogenicity factors, other surface factors
also contribute or are required for full virulence. Lipopolysaccha-
rides (LPS) of Y. enterocolitica serotypes O:3 and O:8 are required
for successful colonization of the gut and play an important role in
the outer membrane integrity of the bacteria [28,29,30]. LPS O
polysaccharide (O-antigen) mutants were attenuated in virulence
and impaired in their ability to colonize the Peyer’s patches, liver
and spleen [30,31]. Production of the O-antigen is also
temperature-regulated with maximal expression at moderate
temperatures [32,33]. A complex network regulates O-antigen
expression at the transcriptional level and the RosA/RosB efflux
pump/potassium antiporter system and Wzz, the O-antigen chain
length determinant, are indirectly involved in the temperature-
dependent control process [33]. In addition, flagella-dependent
motility is required to initiate host cell invasion by ensuring
migration and cell contact of the bacteria [34].
Most studies on Y. enterocolitica virulence factors and their
contribution to virulence were performed using highly mouse-
virulent bioserogroup 1B/O:8 strains, in particular Y. enterocolitica
8081v. However, several other human pathogenic Y. enterocolitica
strains which are less virulent in mice (e.g. serotypes O:3, O:9 and
O:5,27) were also frequently isolated from patients [1]. Among
these strains, Y. enterocolitica bioserotype 4/O:3 is by far the most
frequent cause of human yersiniosis in Europe and Japan (80–
90%). Y. enterocolitica infections are less common in North America.
However, since the 1980s, serogroup O:3 strains have emerged as
an occasional cause of foodborne outbreaks and replaced O:8 as
the predominant serotype of Y. enterocolitica reported to CDC
[35,36,37,38]. They mainly originate from domestic pigs (preva-
lence of 0–65% in fattening pig herds), which are often asymptotic
carriers, and in which they commonly colonize the lymphoid tissue
of the gut and oropharynx [39,40]. As only very little is known
about the pathogenicity of Y. enterocolitica bioserotype 4/O:3, we
compared host cell interactions of different human-, pig- and food-
derived Y. enterocolitica isolates and found that expression and
function of surface-exposed virulence factors of serotype O:3
strains differ significantly from other Y. enterocolitica serotypes. This
may reflect an adaptation of Y. enterocolitica O:3 to the intestine of
pigs which make them also highly pathogenic for humans.
Results
Y. enterocolitica O:3 interaction with epithelial cells differs
significantly from other Y. enterocolitica serotypes
In order to obtain information about interactions of Y.
enterocolitica serotype O:3 (YeO:3) strains with host cells, we first
investigated the adhesion and invasion efficiency of two reference
strains Y11 and YeO3 and 25 different YeO:3 strains isolated
from human patients, animals or food between 2005 and 2008 in
Germany (Table S1). None of the serotype O:3 isolates was able to
efficiently bind and invade into cultured human epithelial cells
when the bacteria were grown at standard culture conditions and
similar patterns of host-cell associated bacteria (adhesion and
invasion) were obtained when infection was performed at 22–25uC
or 37uC (Fig. 1, S1, data not shown). A prolongation of the
infection time from 30 min to 3 hours and/or use of other human,
porcine and murine epithelial cell lines did not significantly
enhance the efficiency of cell adherence (data not shown),
indicating that low-efficiency of adhesion and invasion is
independent of the cell line and host species. In contrast, all other
tested Y. enterocolitica isolates (serotypes O:5,27, O:8 and O:9)
adhered very efficiently and were able to enter all tested epithelial
cell lines after 30 min with a frequency ranging from 20–30%
depending on the serotype and the isolate (Fig. 1, data not shown).
Amotility of Y. enterocolitica O:3 affects cell invasion
efficiency
It is known that motility is an important factor enhancing the
invasion efficiency of yersiniae [34]. We tested motility of the
YeO:3 strains and found that none of the isolates was motile on
swimming and swarming agar plates in contrast to other Y.
enterocolitica serotypes, e.g. Y. enterocolitica YeO:8 8081v (Fig. 2A,
data not shown). Transmission electron microscopy further
revealed that YeO:3 strains are not flagellated (Fig. 2B, data not
shown), indicating that flagella synthesis is abolished or does not
occur under used growth conditions (LB, 25uC). This phenotype
was also observed with YeO:3 strains isolated from liver and
spleen of BALB/c mice three days post infection (data not shown).
Notably, 30–40% of the bacteria isolated from the intestine were
flagellated (Fig. S2) and motile after in vitro cultivation for 24 h
(data not shown). However, none of them remained motile and
flagellated after 48 h, indicating that the bacteria are motile within
the intestinal tract and rapidly repress flagella synthesis when
grown on agar plates.
It has been assumed that motility enhances the frequency of
bacteria-cell interaction and/or provides an additional force for
active cell entry. To investigate whether non-invasiveness of the
serotype O:3 strains was caused by a reduction of host cell contacts
due to amotility, we performed adhesion and invasion assays with
Author Summary
Bacterial infections are generally initiated by molecular
interactions that occur between the pathogen and its host
cell. These interactions are usually mediated by adhesion
and invasion factors exposed from the surface of the
bacteria which are necessary for the colonization of host
tissues and fundamental to pathogenesis. It is well known
that many bacterial species contain several different
adhesin determinants, which often vary between bacteria
of the same species, reflecting the fact that each microbe
has adapted to a distinct ecological niche. Here, we show
that also small alterations changing the expression pattern
of adhesins and virulence gene regulators in response to
environmental factors (e.g. temperature) lead to funda-
mental differences in pathogen-host cell interactions and
pathogenesis. Modulation of virulence gene expression
constitutes an ideal mechanism to adjust virulence-
associated processes of pathogens to different hosts (e.g.
with varying body temperature) as it allows the bacteria to
readjust expression of certain gene subsets of regulatory
networks controlling virulence, stress and metabolic
adaptation to their demands in individual hosts.
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When we pre-grew the bacteria at 25uC, adhesion and
internalization was slightly increased after centrifugation, but the
overall efficiency was still significantly lower compared to YeO:8
8081v. This demonstrated that amotility of the bacteria reduced
host cell contact and invasion of YeO:3 grown at 25uC. However,
this does not fully explain the observed differences. In this context,
we also analyzed host cell adhesion and invasion of bacteria grown
at 37uC (Fig. 3B). Without centrifugation, the number of adherent
YeO:8 8081v was significantly reduced and no invasion of the
bacteria was detectable at 37uC. In contrast, YeO:8 8081v
adhered tightly to HEp-2 cells after bacteria were artificially
brought into cell contact by centrifugation, but they were not
internalized (Fig. 3B). This is consistent with previous studies
showing that synthesis of the flagella and the primary internali-
zation factor invasin is repressed at 37uCi nY. enterocolitica 8081v,
whereas production of the major adhesion factor YadA is induced
at 37uC but not at moderate growth temperatures [15,41]. As
shown in Fig. 3B, pre-growth at 37uC and artificially induced host
cell contact led to a significant raise of cell adhesion of all tested
O:3 strains. Notably, only under these conditions efficient host cell
invasion of YeO:3 strains was as efficient as cell uptake obtained
with YeO:8 8081v grown at 25uC (20–30% of adherent bacteria).
Since efficient cell adhesion and internalization of YeO:3 strains
was only achieved after artificial host cell contact, in all following
experiments bacteria were centrifugated onto host cells.
Internalization of Y. enterocolitica O:3 into human
epithelial cells
Based on the previous experiments it seemed possible that an
additional thermo-regulated internalization mechanism is responsible
for host cell invasion at 37uC. To compare the invasion mechanism
used by YeO:3 and YeO:8 strains, we monitored cell entry of YeO:8
8081v grown at 25uC and YeO:3 Y1 grown at 37uCi n t oH E p - 2
(Fig. 4A) and Caco-2 (data not shown) cells by scanning electron
microscopy. We found that adherence and invasion of both Y.
enterocolitica serotypes showed very common features and were not cell
type specific. After host cell binding, the cell surface in the vicinity of
the microbes seems to be slightly drawn down, pseudopodia and
lamellipodia are formed and the eukaryotic cell membrane then
seems to enclose and surround the bacteria into a membrane-bound
vacuole. In contrast, no cell adherence of YeO:3 strain Y1 was
observed when grown at 25uC, and only simple attachment, but no
formation of membrane protrusions was detectable when YeO:8
8081v was precultivated at 37uC (data not shown). This suggested
that the internalization mechanism initiated by Y.enterocoliticaserotype
O:3 and O:8 strains is similar but expressed at different temperatures.
Expression analysis of Y. enterocolitica O:3 invasin
Inordertotest thishypothesis,weanalyzed theamountofinvasin
in both Y. enterocolitica serotypes and found that high amounts of the
primary invasion factor invasin were present in all tested YeO:3
Figure 1. Y. enterocolitica O:3 interaction with epithelial cells. Ten different Y. enterocolitica serotype O:3 isolates from human patients or pigs,
Y. enterocolitica O:8 strain 8081v, Y. enterocolitica O:9 strain 4620 and Y. enterocolitica O:5,27 strain 3056 were grown at 25uC overnight in LB medium.
About 5?10
4 HEp-2 cells were infected with 5?10
5 bacteria and incubated at 22–25uC to monitor cell association or 37uC to determine the
internalization efficiency of the bacteria by the gentamicin protection assay. E. coli K-12 was used as negative control. Data are presented as means 6
standard deviations of three independent experiments performed in duplicate.
doi:10.1371/journal.ppat.1002117.g001
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detectable at 25uC, but not at 37uC (Fig. 5AB). Production of
invasin in YeO:3 strains at 37uC explains why the invasion rate is
significantly enhanced at this growth temperature. However, this
also raised the question why no internalization of the bacteria was
observed when the bacteria were grown at 25uC, although similar
amounts of the invasin protein were produced (Fig. 3, 5).
Y. enterocolitica O:3 O-antigen blocks InvA-mediated
invasion at 25uC
To decipher the differences in the host cell invasion properties
between the Y. enterocolitica O:3 and O:8 serotype, we first performed
adhesion and invasion experiments with E. coli K-12 expressing the
invAO:3 and invAO:8 genes and found a similar ability of both invasin
proteins to promote cell attachment (25%) and entry (5%) (data not
shown). This led to the hypothesis that a temperature-regulated
surface structure might block invasin function of YeO:3 strains at
moderate growth temperatures. Indeed, composition of the outer
membrane and particularly make-up of LPS was shown to be
strongly temperature-dependent in Y. enterocolitica [32]. Both the
branched outer core hexasaccharide (OC) and the homopolymeric
O-antigen (O-Ag) of the unique YeO:3 LPS are maximally produced
below 30uC, whereas only very reduced levels of these LPS
components are displayed on the bacterial surface at 37uC[ 3 2 ] .I n
order to investigate whether they sterically block the access of invasin
to host cells, we used different mutant strains of Y. enterocolitica O:3
Figure 2. Motility and flagellation of Y. enterocolitica O:3 and O:8. (A) Swimming of Y. enterocolitica O:3 (Y1) and O:8 (8081v). Aliquots of 2 ml
of the bacterial culture were inoculated onto LB swimming plates. The plates were incubated at 25uC for 48 h. (B) Transmission electron microscopy
of Y. enterocolitica O:3 (Y1) and O:8 (8081v) grown to stationary phase. Bars indicate 2 mm and 1 mm, respectively.
doi:10.1371/journal.ppat.1002117.g002
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thesis (YeO3-OC), or both (YeO3-OCR) [42]. As shown in Fig. 6A,
both O-Ag deficient mutant strains (YeO3-R2, YeO3-OCR) have an
increased capacity to interact and enter human epithelial cells,
whereas no difference was detectable with the OC knock-out mutant
(YeO3-OC). When the adhesion and uptake assays were performed
at 37uC, the overall adhesion and invasion levels of the YeO3 wild-
type strain were significantly increased and identical to that of YeO:8
8081v grown at 25uC, and no significant differences were observed in
the absence of the O-Ag or the OC (Fig. 6A). Notably, differences in
host cell interactions did not result from differences in invA or yadA
expression as identical amounts of invasin and YadA were detectable
in the Y. enterocolitica O:3 wild-type YeO3 and the O-Ag and OC
mutants grown at 25uCa n d3 7 uC( F i g .6B). Taken together, these
data strongly suggest that the YeO:3 O-Ag reduces host cell
interactions at 25uC, most likely through steric hindrance of
adhesin/invasin host cell receptor binding. However, this does not
seem to be the only reason why YeO3 is less invasive at 25uCt h a n
YeO8 8081v, as invasion of the O-Ag mutant strains was still lower
compared to invasion of the Y. enterocolitica O:8 strain (Fig. 6A).
Co-expression of invasin and YadA is necessary for
efficient invasion at 37uC
Besides invasin, also the virulence plasmid-encoded YadA
protein promotes tight adhesion of Y. enterocolitica to host cells
[43]. We first investigated expression of the yadA gene in response
to temperature and found that similar amounts of YadA are
produced in all tested Y. enterocolitica O:8 and O:3 strains at 37uC
(Fig. 5B, 6B) whereas no synthesis could be detected at 25uC (data
not shown). Furthermore, we analyzed cell adhesion and
internalization of Y. enterocolitica O:3 strain Y1 grown at 25uCo r
37uC in the presence and absence of invasin or YadA (Fig. 7A),
and confirmed production or loss of adhesins in the equivalent Y.
enterocolitica strains (Fig. 7B). Deletion of the invA gene had no effect
on host cell binding, but eliminated the ability of the YeO:3 strains
to invade human epithelial cells independently from growth
temperature. This phenotype was fully complemented by an invA
expression plasmid. In contrast, loss of YadA had no effect on host
cell invasion and cell adherence at 25uC. However, host cell
binding and invasion were significantly reduced when yadA-
deficient bacteria were grown at 37uC. Overexpression of the yadA
gene under control of an inducible promoter (PBAD) complemented
this phenotype and increased cell binding and entry levels at 37uC.
Even more strikingly, it promoted highly efficient cell adhesion
and invasion of bacteria grown at moderate temperature, similar
to YeO:8 8081v (Fig. 7A). Thus, co-expression of both adhesins is
required to permit efficient cell binding and internalization of
serotype O:3 strains into host cells: YadA is needed to maximize
adhesion whereas invasin is necessary to initiate the internalization
process.
Figure 4. Y. enterocolitica O:3 and O:8 interaction with epithelial cells. Y. enterocolitica O:3 strain Y1 was pregrown at 37uC and Y. enterocolitica
O:8 strain 8081v was grown at 25uC. The bacteria were added to HEp-2 and incubated for 30 min at 37uC after centrifugation of the bacteria onto the
monolayer. Different stages of the internalization process are shown (initial binding, filopodia and lamellipodia formation). Bars indicate 1 mm.
doi:10.1371/journal.ppat.1002117.g004
Figure 3. Host cell interaction of Y. enterocolitica O:3 by InvA at 256C is less efficient due to amotility. Amotile Y. enterocolitica O:3 strains
YeO3, Y11, and Y1 and motile Y. enterocolitica strain O:8 8081v were grown at 25uC( A)o r3 7 uC( B) overnight. About 5?10
4 HEp-2 cells were infected
with 5?10
5 bacteria and incubated with or without centrifugation of the bacteria onto the monolayer to monitor cell association (adhesion+invasion)
or the internalization efficiency of the bacteria by the gentamicin protection assay. E. coli K-12 was used as negative control. Data are presented as
means 6 standard deviations of three independent experiments performed in duplicate.
doi:10.1371/journal.ppat.1002117.g003
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Our previous experiments clearly demonstrated that the
absence of YadA results in low invasiveness of YeO:3 strains at
25uC, despite the presence of invasin. Yet, invasin expression at
37uC is a special feature of serotype O:3 strains, as it is not
produced in other previously characterized Yersinia strains, e.g.
YeO:8 8081v (Fig. 5) [15] and Y. pseudotuberculosis [44]. Therefore,
we started to elucidate the molecular mechanisms underlying such
differences. First, the invA coding and regulatory region of all Y.
enterocolitica O:3 isolates used in this study were sequenced and an
IS1667 element inserted at position 2143 of the invA promoter
was identified (Fig. 8A). To address whether presence of the
IS1667 insertion is restricted to strains of the same geographic
region isolated over a relatively short timeframe, we also
sequenced the invA locus of 22 additional Y. enterocolitica O:3
isolates collected from all over the world between 1973 and 2008
(Table S1). All tested isolates contained the IS1667 element at the
same position within the invA regulatory region. To test the
influence of the inserted IS element, we compared the activities of
the invA promoter of YeO:8 8081v (PinvO:8) and YeO:3 Y1 wild-
type (PinvO:3) or after deletion of the IS1667 insertion (PinvO:3DIS).
We found that integration of the mobile element is accompanied
with a much stronger expression of the invA promoter. As shown in
Fig. 8B, expression of the PinvO:3DIS::luxCDABE and the PinvO:8::
luxCDABE fusions were very similar and significantly lower than
PinvO:3::luxCDABE expression at 37uC. This result is consistent with
a western blotting analysis showing that invasin production is
considerably higher in the YeO:3 strains than in YeO:8 strain
Figure 5. Expression analysis of Y. enterocolitica O:3 invasin, YadA, and RovA. Y. enterocolitica O:3 strains and the serotype O:8 reference
strain 8081v were grown overnight at 25uC( A) and 37uC( B). Whole cell extracts for analysis of the DNA-binding protein RovA and the adhesins InvA
and YadA were prepared, separated on SDS-polyacrylamid gels and analyzed by western blotting using polyclonal antibodies directed against RovA,
InvA and YadA. A molecular marker the PageRuler Prestained Protein Ladder was loaded on the left.
doi:10.1371/journal.ppat.1002117.g005
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linear and often stronger signal than the relative change in
transcription, we also performed a quantitative RT-PCR analysis
and observed a 6.5-fold reduction of relative invA mRNA levels in
the DIS1667 mutant YE15 compared to the wild-type strain (Fig.
S3).
To find out whether higher activation of the invO:3 promoter
was due to the insertional inactivation of inhibitory sequences (e.g.
H-NS binding sites) or to the presence of specific IS sequences
different portions of the invA upstream region were deleted and
transcription of the PinvO:3::luxCDABE fusion in the Y1 wild-type
strain was analyzed. High expression of the PinvO:3::luxCDABE
fusion was obtained with deletion constructs harboring sequences
upstream of position 2448, whereas PinvO:3 promoter activity was
severely reduced with the fusions starting at or downstream from
position 2248 (Fig. 8C). This demonstrated that the PinvO:3
activity cannot solely be caused by insertional inactivation of
inhibitory sequences, and indicated that an IS-encoded function
contributes to PinvO:3 activation. In fact, insertion of the IS1667
sequences from position 2448 and 2144 upstream of the
promoterless luxCDABE operon resulted in strong expression of
the fusion construct, indicating that an additional promoter
(PIS1667) oriented outward of the IS element drives invAO:3
expression (Fig. 8B). In fact, primer extension analyses revealed
a strong IS-encoded promoter (PIS1667) with a 235 region located
upstream and the 210 region downstream of position 2248.
PIS1667 initiated transcription from position 2219 with respect to
the transcriptional start site of a second promoter (PinvA) located
within the invA regulatory region (Fig. 8D, S4). PinvA was equal to
the invA promoter of Y. enterocolitica O:8 [15] and exhibited a
similar activity when the inserted IS1667 element was deleted
(Fig. 8B).
Since the IS1667 is inserted into the 39-end of the binding site I
of the transcriptional activator protein RovA (Fig. 8A) [45,46], we
also analyzed whether invA expression in Y. enterocolitica O:3 strain
Y1 is still dependent on RovA. We found that invA mRNA levels
and the activity of all highly activated PinvO:3::luxCDABE fusions
starting from position 21830, 21169 and 2448 were significantly
reduced in the absence of the rovA gene, demonstrating that strong
enhancement of invA expression by the IS-encoded promoter still
requires the function of the transcriptional activator protein
(Fig. 8C, S3).
Previous footprint analysis revealed that RovA interacts with
two distinct binding sites of the Y. pseudotuberculosis invA promoter
[46], and sequence homology as well as RovA band shift analysis
indicated that similar binding sites are also recognized by RovA in
the invA regulatory region of YeO:8 8081v [45]. RovA-binding site
I was partially destroyed by the insertion of the IS1667 element in
the invAO:3 promoter (Fig. 9A). However, band shift analysis with
purified recombinant RovA and different DNA fragments of the
invA promoter region demonstrated that RovA still interacts
specifically with RovA sequences upstream of the IS1667 element
containing major parts of binding site I (Fig. 9B). Interestingly,
RovA was also found to specifically interact with fragments
harboring the 39-end (2342 to 2146) of the integrated mobile
element, although a slightly higher concentration was required for
RovA-DNA complex formation. This demonstrated that this
portion of the IS1667 element includes sequences, which are also
preferentially recognized by RovA.
It is very likely that RovA is needed to alleviate H-NS-mediated
repression at sites located downstream of the IS1667 insertion
(Fig. 9A) to permit maximal transcription of the invA promoter. To
test this hypothesis, we also studied the interaction of H-NS with
different fragments of the invO:3 promoter region. As shown in
Fig. 9C, H-NS was able to preferentially interact with a fragment
harboring the 39-portion of the IS1667 element (2342 to 2146),
but the affinity was slightly lower compared to H-NS binding to
the invA promoter fragment (272 to +103). This strongly suggests
that RovA is still required to eliminate H-NS mediated repression
to allow optimal expression of invasin by the PIS1667 and the PinvO:3
promoter.
Enhanced RovA production in Y. enterocolitica O:3 strains
Requirement of RovA for invA transcription in Y. enterocolitica
O:3 at 37uC was unexpected as it has been shown that rovA
expression in Y. enterocolitica O:8 and Y. pseudotuberculosis strains is
strongly thermoregulated and only expressed at moderate
temperatures [44,47]. The RovA protein was found to act as a
thermosensor which undergoes a conformational change upon a
temperature shift from 25uCt o3 7 uC. This thermo-induced
conformational change reduces the DNA binding activity of the
regulatory protein and renders it more susceptible to proteolysis by
the Lon protease [18]. As a result, RovA activation of invA
expression is abolished at 37uC. Although RovA was shown to
activate invA expression in Y. enterocolitica O:3 (Fig. 8C), invasin
expression does not appear to be strongly temperature-regulated
compared to other Yersinia strains (Fig. 5, 6B [15,44]).
To better understand the different control mechanisms, rovA
expression in the different Y. enterocolitica isolates was analyzed. We
found that all YeO:3 isolates produced very high levels of RovA at
25uC and 37uC; whereas no RovA was detected at 37uC in other
Yersinia strains, e.g. YeO:8 strain 8081v and Y. pseudotuberculosis
(Fig. 5, data not shown [44,47]). Expression analysis of the
ProvAO:3::lacZ and ProvAO:8::lacZ fusions revealed that both rovA
promoters are not auto-activated and are either not or only very
weakly dependent on the temperature (Fig. 10A, S6). Next, we
addressed whether thermo-sensing and proteolysis varies between
the RovAO:8 and RovAO:3 proteins. We introduced low-copy
plasmids carrying the rovAO:3 gene of YeO:3 Y1 or the rovAO:8
gene of YeO:8 8081v into a Y. enterocolitica O:3 rovA mutant strain
(YE12) and compared RovA levels after growth at 25uC and 37uC
(Fig. 10B). Almost identical levels of the RovA proteins were
detected at 25uC. However, significantly lower amounts of the
RovAO:8 protein were visible at 37uC, while RovAO:3 concentra-
tions remained almost the same (Fig. 10B). This strongly suggested
that post-transcriptional mechanisms controlling RovA levels must
be different in YeO:3 strains. To test this hypothesis, we sequenced
the rovA locus of all 49 available Y. enterocolitica O:3 strains (Table
S1). We found that the rovA genes of 45 strains, including all
isolates tested in this study vary from rovA of other Y. enterocolitica
Figure 6. Influence of the Y. enterocolitica O:3 O-antigen on host cell invasion. Y. enterocolitica wildtype strains YeO3 and 8081v, and outer
core and/or O-antigen deficient derivatives (YeO3-OC, YeO3-R2, YeO3-OCR) were grown at 25uC and 37uC. (A) About 5610
4 HEp-2 cells were infected
with 5610
5 bacteria. After centrifugation of the bacteria onto the monolayer, cell association (adhesion+invasion) was monitored and internalization
efficiency of the bacteria was determined by the gentamicin protection assay. E. coli K-12 was used as negative control. Data are presented as means
6 standard deviations of three independent experiments performed in duplicate. Data were analyzed by the students t test. Stars indicate the results
that differed significantly from those of YeO3 with * (P,0.05), ** (P,0.01), and *** (P,0.001) (B) Whole cell extracts were prepared from overnight
cultures, separated on SDS-polyacrylamide gels and analyzed by western blotting using polyclonal antibodies directed against InvA and YadA. As a
molecular marker the PageRuler Prestained Protein Ladder was loaded on the left.
doi:10.1371/journal.ppat.1002117.g006
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P98S change in the amino acid sequence of the translated
regulatory protein. To find out whether this substitution affects
function of RovA as a thermosensor, we overexpressed and
purified RovA of YeO:8 8081v and YeO:3 Y1 and compared their
DNA-binding capacity at 25uC and 37uC (Fig. S5). However,
interaction of both RovA variants with DNA fragments of the invA
regulatory region was still temperature-dependent. Significantly
more of both RovA proteins was required at 37uC for RovA-DNA
complex formation, indicating that the thermosensing function is
not severely affected by the P98S exchange. Next, we addressed
thermo-dependent susceptibility of the RovA variants to degrada-
tion by the Lon protease. To this aim, we reintegrated a copy of
the rovAO:3 or rovAO:8 gene into the genome of a rovA deficient
YeO:3 strain (YE12) and performed stability assays. Identical
amounts of RovAO:3 were still visible 90 min after protein
biosynthesis was stopped (Fig. 10C). In contrast, the RovAO:8
protein was rapidly degraded at 37uC, and significantly lower
amounts of the regulatory protein were detectable 90 min after
cessation of protein synthesis.
Influence of higher RovA and invasin levels in YeO:3 on
invasion and virulence
To test the effect of the IS1667 insertion in the invA promoter
and the more stable RovAO:3(S98) variant on host cell invasion, we
compared the amount of produced invasin and RovA in YeO:3
strains YE13 (rovAO:3), YE14 (rovAO:8) and YE15 (PinvO:3DIS)
(Fig. 11A) and investigated the efficiency of these bacteria to
enter HEp-2 cells (Fig. 11B). High levels of invasin were detectable
in YE13, whereas the instable RovA variant and deletion of the
IS1667 element produced lower amounts of invasin, leading to a
significant reduction of invasiveness into human epithelial cells.
It was previously shown that invasin and RovA are important to
invade the intestinal epithelium by Y. enterocolitica O:8 early after
infection. The rovA-deficient mutants were found to be attenuated
in the ability to reach and/or replicate in the deeper tissues and
organs and induce a milder inflammation of the Peyer’s patches
[48], whereas the LD50 values of the wild-type and the invA mutant
were essentially identical but the colonization of the host tissues
was delayed [4]. In order to determine whether higher invasin and
RovA levels in Y. enterocolitica O:3 also affect pathogenesis, we
tested the virulence of wild-type and mutant strains in the murine
infection model. First, single strain infections were performed and
bacterial colonization of Peyer’s patches (PPs), mesenteric
lymphnodes (MLNs), liver and spleen was assessed. Since only
minor differences could be highlighted (data not shown), we
performed co-infection experiments to determine whether pres-
ence of the wild-type affects the ability of the mutants to colonize
tissues in a single host. This minimizes inherent inter-animal
biological variations and can expose even subtle differences of the
biological fitness and virulence, e.g. in the kinetics of infection.
BALB/c mice were orally infected with 5610
8 bacteria in an
inoculum comprised of an equal mixture of (i) the parental Kan
S
wild-type strain Y1 (rovAO:3(S98)) and the Kan
R mutant strain YE14
(rovAO:8(P98)) or (ii) Y1 and YE15 (PinvO:3DIS) harboring a stable
vector which only differs in its antibiotic resistance cassette to
establish the ability to discriminate strains. Three days after
infection, mice were dissected and the numbers of bacteria present
in the PPs, MLNs, liver or spleen were determined (Fig. 12). The
results of the infection showed that both, the parental (YE13
rovAO:3(S98)) and the rovAO:8(P98) mutant strain (YE14) are capable
of establishing an infection, but considerably higher numbers of
bacteria encoding the less stable RovAO:3(P98) variant from YeO:8
(YE14) were recovered from all dissected tissues. About 2- to 10-
fold more bacteria of this strain were isolated from the lymphatic
tissues or the organs (Fig. 12A) compared to the parental strain
YE13 (rovAO:3(S98)). Also comparison of the relative virulence ratio
(Fig. 12B) and calculation of the competitive index of the mutant
relative to the wild-type strain (Fig. 12C) indicated that higher
concentrations of RovA during mouse infections at 37uC are
disadvantageous for the colonization and multiplication of YeO:3
in the organs. In contrast, significantly lower numbers of strain
YE15 lacking the IS1667 element in the invA promoter region
were isolated. About 10–20 times less bacteria were recovered
from the PP and MLNs (Fig. 12A). The difference in the
dissemination of the bacteria was even more striking. The IS1667
deletion strain YE15 was strongly attenuated in its ability to reach
deeper tissues. Only in some occasions it reached the liver and
spleen, but the bacterial load of the mutant in the liver and spleen
was always significantly lower compared to wild-type (Fig. 12). In
summary, these data strongly indicates that high invasin
expression levels during the course of an infection combined with
a fine-tuned control of the virulence regulator RovA are
advantageous for YeO:3 virulence in mice.
Discussion
The ability of Y. enterocolitica to bind and invade into host cells is
essential for pathogenesis and persistance in its human host.
Results of the present investigation highlight important differences
in the adhesion properties between serotype O:3 strains (respon-
sible for more than 70% of human yersiniosis cases) and other Y.
enterocolitica serotypes, e.g. serotype O:8, whose pathogenicity has
been extensively investigated. Comparative analysis of cell binding
properties demonstrated that the same repertoire of virulence
factors is implicated in host cell binding in the serotype O:3
isolates, but their interplay and expression profile in response to
environmental signals is significantly different from O:8 strains
(Fig. 13).
We show that synthesis of the primary internalization factor
invasin is highly activated and nearly constitutive in all tested Y.
enterocolitica O:3 strains. This is in contrast to O:8 serotypes in
which invasin synthesis is repressed at 37uC due to H-NS
mediated silencing and rapid degradation of the invA activator
protein RovA. Interestingly, a previous study also reported that
invA expression of a serotype O:9 strain was higher than in
serotype O:8, but it was still significantly reduced at 37uC [49].
Constitutive expression of the invA gene in the O:3 strains was
acquired by an IS1667 insertion into the invA regulatory region
Figure 7. Coexpression of invasin and YadA is necessary for efficient invasion at 376C. Y. enterocolitica strain O:8 strain 8081v, Y.
enterocolitica O:3 strain Y1 and isogenic invA and yadA deficient mutant derivatives were grown overnight at 25uC and 37uC. (A) About 5?10
4 HEp-2
cells were infected with 5?10
5 bacteria and after centrifugation of the bacteria onto the monolayer the samples cell association (adhesion+invasion)
was monitored and internalization efficiency of the bacteria was determined by the gentamicin protection assay. Data are presented as means 6
standard deviations of three independent experiments performed in duplicate. Data were analyzed by the students t test. Data were analyzed by the
students t test. Stars indicate the results that differed significantly from those of Y1 with * (P,0.05), ** (P,0.01), and *** (P,0.001). (B) Whole cell
extracts were prepared from the overnight cultures, separated on SDS-polyacrylamide gels and analyzed by western blotting using polyclonal
antibodies directed against InvA and YadA. As a molecular marker the PageRuler Prestained Protein Ladder was loaded on the left.
doi:10.1371/journal.ppat.1002117.g007
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PLoS Pathogens | www.plospathogens.org 11 July 2011 | Volume 7 | Issue 7 | e1002117Figure 8. Analysis of invA expression in Y. enterocolitica O:3. (A) An overview of the invA promoter region including the IS1667 insertion of Y.
enterocolitica O:3 strains is shown. The transcriptional start sites of the invA gene and from the predicted IS1667-encoded promoter are indicated by
broken arrows, the dark boxes indicate the RovA binding sites identified in the homologous invA promoter of Y. pseudotuberculosis. The thick line
represents the invA promoter sequence and the thin line illustrates the IS1667 sequence. The arrow indicates the gene encoding the putative
transposase of the IS1667 element. Sites used for the upstream deletion constructs are indicated by arrows. The numbers indicate the position of the
deletion relative to the transcriptional start site of the invA gene. (B) Overnight cultures of Y. enterocolitica O:3 strain Y1 harbouring the
PinvAO:8::luxCDABE (pFU170), PinvAO:3::luxCDABE (pFU171), PinvAO:3DIS::luxCDABE (pFU172) and PIS1667::luxCDABE (pFU202) fusion constructs were diluted
(1:100) and grown in LB at 37uC for four hours and luciferase activity was determined. (C) Expression by progressive deletion of the invA 59-regulatory
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transposons has been described for other genetic systems but the
induction mechanism of the Y. enterocolitica O:3 invA gene seems
distinct from previously reported systems. Transposable elements
usually activate gene expression by replacing a negative regulatory
element or through introduction of promoter elements [50,51].
One of the best-characterized examples of transposon-mediated
gene activation is the beta-glucoside (bgl) operon of E. coli. This
region was analyzed in Y. enterocolitica O:3 Y1 and the isogenic rovA mutant derivative Y12 harbouring the PinvAO:3::luxCDABE fusion. The numbers
indicate the 59 end points of the regulatory region of invA from Y. enterocolitica O:3 in the fusion constructs relative to the transcriptional start site
(+1). The luciferase activity determined from the cultures is given in relative light units (RLU) and represents the mean 6 standard deviation of at least
three independent experiments. (D) Sequence of the 39-end of the IS1667 inserted into invA of Y. enterocolitica O:3 at position 2143 is shown. The
210 and 235 region of the predicted IS1667-encoded promoter are indicated. Sites used for the upstream deletion constructs are indicated by
arrows. The numbers indicate the position of the deletion relative to the transcriptional start site of the invA gene.
doi:10.1371/journal.ppat.1002117.g008
Figure 9. RovA and H-NS binding to the Y. enterocolitica O:3 invA regulatory region. (A) Overview of the invA promoter region of Y.
enterocolitica O:3 strains. The transcriptional start sites of the invA promoter and of the predicted IS1667-encoded promoter are indicated by broken
arrows. The dark boxes represent the RovA and the white small boxes the H-NS binding sites identified in the homologous invA promoter of Y.
pseudotuberculosis. The thick line represents the invA promoter sequence and the thin line illustrates the sequence of the IS1667 element with the
putative transposase gene. Fragments used for the band shift experiments are shown as black lines. Competitive gel retardation assays using purified
RovA protein (B) or purified H-NS (C)o fY. enterocolitica O:3 strain Y1. DNA fragments comprising different portions of the invA regulatory region of
Y1 were incubated without or with increasing concentrations of purified RovA or H-NS. The DNA-protein complexes were separated on a 4%
polyacrylamide gene, a molecular weight standard 100 bp ladder was loaded on the left. The higher molecular weight protein-DNA complexes are
marked by an arrow and the positions of the non-shifted and control fragments are indicated.
doi:10.1371/journal.ppat.1002117.g009
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PLoS Pathogens | www.plospathogens.org 13 July 2011 | Volume 7 | Issue 7 | e1002117Figure 10. Analysis of RovA production and stability in Y. enterocolitica O:3. (A) Y. enterocolitica strains Y1 and the isogenic rovA mutant of
Y1 (YE12) harboring plasmids encoding the promoterless lacZ gene or the ProvAO:8-lacZ or ProvAO:3-lacZ fusions were grown at 25uC and 37uC
overnight. The beta-galactosidase activity determined from the cultures is given in mmol min
21 mg
21 and represents the mean 6 standard deviation
of at least three independent experiments. (B)AY. enterocolitica O:3 DrovA mutant strain (YE12) harboring the rovA encoding plasmids pFU119
(rovAO:3) or pFU138 (rovAO:8) and YeO:8 strain 8081v were grown overnight at 25uC and 37uC. Whole cell extracts were prepared from the cultures,
separated on SDS-polyacrylamide gels and analyzed by western blotting using polyclonal antibodies directed against RovA. As a molecular marker
the PageRuler Prestained Protein Ladder was loaded on the left. (C) Isogenic Y. enterocolitica strains YE13 and YE14 expressing the RovA wildtype
protein or the RovAS98P derivative were grown to exponential phase (OD600=0.6–0.7) at 37uC before gentamicin (50 mgm l
21) and tetracycline
(50 mgm l
21) were added. The cultures were incubated at 37uC for additional 90 min. Aliquots of the cultures were removed at the indicated times
thereafter, whole cell extracts for identical numbers of bacteria were prepared and intracellular RovA was visualized by western blotting.
doi:10.1371/journal.ppat.1002117.g010
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up- or downstream of the promoter in either orientation relieving
H-NS repression [52,53]. However, deletion analysis revealed that
transposon-mediated invA activation in Y. enterocolitica O:3 is not
solely due to disruption of the inhibitory H-NS binding sites, but
also requires an IS-specific activating element. One recent study
revealed a novel transposon-mediated gene activation mechanism.
An IS5 insertion at a single site and in only one orientation was
found to activate expression of the glpFK operon in a crp
background [54]. A short sequence at the 39 end of the IS5
transposon, including a permanently bent polyA-tract and an IHF
binding site, was shown to be required for glpFK induction. This
shows that unique sequences within a mobile element can act as an
enhancer or gain an activator binding function sufficient to
activate close promoters. In this study we found that IS1667-
promoted activation of invA expression in Y. enterocolitca O:3 at
25uC and 37uC is largely dependent on the presence of an IS1667-
generated promoter and alternative RovA (activator) and H-NS
(silencer) binding sites. RovA of YeO:8 was previously shown to
activate invA expression only at moderate temperatures through
antirepression of H-NS-mediated silencing [45]. A temperature
upshift to 37uC, however, results in a conformational change
within RovA that strongly reduces the DNA-binding capacity of
the regulator. It has been previously shown that the apparent
dissociation constant (Kd) of the thermoregulated RovA protein of
Y. pseudotuberculosis is about four-fold increased upon a temperature
shift from 25uCt o3 7 uC [18]. Furthermore, it was found that the
temperature upshift renders the RovA protein more susceptible to
degradation by the Lon and ClpP proteases [18]. Comparable
studies with the RovA protein of YeO:8 8081v demonstrated
similar properties and identical function as an intrinsic thermo-
sensor (F. Uliczka, unpublished data). Here, we found that a single
proline to serine exchange at position 98 (P98S) increases the
stability of YeO:3 RovA without affecting the thermosensing
ability of the protein. As a consequence, significantly higher RovA
concentrations are present within the bacteria and this is sufficient
to compensate for the thermo-induced reduction of RovA DNA
binding. As YeO:3 strains originate mainly from boars and pigs
with a higher body temperature of about 39u–40uC, a more
temperature-stable RovA variant might be advantageous for
persistence in these animals. According to our proposed structure
model of RovA [55] the amino acid P98 is located in a surface
exposed loop structure and is as such easily accessible for the
proteases. How the P98S mutation affects proteolytic degradation
is not yet clear. However, comparative CD spectroscopy of
purified RovAO:8(P98) and a RovAO:3(S98) variant of Y. pseudotuber-
Figure 11. Influence of enhanced invasin and RovA levels on Y. enterocolitica O:3 host cell invasion. (A) Whole cell extracts were
prepared from the cultures, separated on SDS-polyacrylamide gels and analyzed by western blotting using polyclonal antibodies directed against
InvA and RovA. As a molecular marker the PageRuler Prestained Protein Ladder was loaded on the left. (B) YeO:3 strains Y1 (wt), YE13 (rovAO:3S98),
YE14 (rovAO:8P98) and YE15 (rovAO:3DIS1667) were grown at 37uC. Approximately 10
6 bacteria were centrifugated onto 10
4 HEp-2 cells. Total numbers
of intracellular bacteria were determined and are expressed relative to the invasion rate of YeO:3 strain Y1 defined as 100%. Each value represents the
mean of at least three different assays done in triplicate. Data were analyzed by the students t test, **, significantly different from Y1 or YE13 with
P,0.001.
doi:10.1371/journal.ppat.1002117.g011
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this amino acid substitution (N. Quade, unpublished results).
Furthermore, proteolysis is drastically reduced but not completely
blocked by the P98S mutation as a slightly higher concentration of
the regulatory protein was detected in a Yersinia lon mutant strain.
In summary, a more stable RovA variant (RovAO:3(S98)) and an
IS1667 insertion in the invA promoter region, providing an
additional promoter followed by slightly weaker RovA and H-NS
binding sites, allow high expression levels of invasin in YeO:3
strains at 37uC. How these different properties influence
pathogenesis is not fully clear, but first experiments addressing
host cell invasion and colonization of YeO:3 in the mouse model
revealed that loss of the IS1667 element reduced host cell entry
and had a severe effect on the infection process in mice.
Colonization of the PPs and the MLNs by YeO:3 strain YE15
(PinvO:3DIS) was significantly reduced and only occasionally these
bacteria were able to reach deeper organs in co-infection
experiments. This indicates that high levels of invasin are more
advantageous and/or important for YeO:3 to initiate a successful
infection than for YeO:8 in mice. In fact, a YeO:8 8081v invA
mutant strain shows a delayed but still efficient colonization of
deeper tissues [4,56].
In contrast to invasin, loss of the RovA regulator in YeO:8
8081v leads to a 70-fold increase of the LD50 and causes a much
more severe alteration of the infection kinetics, e.g. penetration of
the Peyer’s patches and mesenterial lymph nodes was much more
reduced, and dissemination into liver and spleen was abolished
[56]. Interestingly, significantly higher numbers of bacteria could
be detected in lymphatic tissues and organs of mice when the
unstable variant RovAO:3(S98) was expressed by YeO:3. This
strongly suggests that elevated RovA levels, although they lead to
higher amounts of invasin are disadvantageous for the colonization
of the organs in mice. Microarray analysis to define the RovA
regulon of Y. enterocolitica in YeO:8 revealed 40 genes to be
activated and 23 repressed by RovA [57]. Among the RovA-
repressed loci are several metabolic genes, e.g. permeases for
glutamine, glutamate and aspartate) and their upregulation due to
reduced RovA levels at 37uC might be important for the biological
fitness and survival in host tissues during infection in mice. A more
stable but still thermo-sensitive RovA variant, as found in YeO:3
Figure 12. Influence of enhanced invasin and RovA levels on Y. enterocolitica O:3 virulence. (A) BALB/c mice were co-infected via the
orogastric route with 5610
8 bacteria in an inoculum comprised of an equal mixture of YeO:3 strains Y1 (wt, rovAO:3) and YE14 (rovAO:8), or Y1 (wt,
rovAO:3) and YE15 (rovAO:3PinvDIS). Three days post infection, the mice were sacrificed and the numbers of surviving bacteria in the liver, spleen,
mesenterial lymph nodes (MLN), and Peyer’s patches (PP) were determined as described in Material and Methods. Data are presented as a scatter plot
of numbers of cfu per gram of organ as determined by counts of viable bacteria on plates. Each spot represents the cfu count, in the indicated tissue
samples from one mouse. The levels of statistical significance for differences between test groups were determined by the Mann-Whitney-test. Stars
indicate results that differed significantly from those of Y1 with ** (P,0.01), and *** (P,0.001). (B) Data are graphed as competitive index values for
the tissue samples from one mouse. The bars represent the means of the competitive index values. A competitive index score of 1 denotes no
difference in the virulence compared to Y1. Underlined scores denote where statistically significant differences were observed. The two strains Y1 and
Y15 used for competition assays were differentially marked with antibiotics resistances on plasmids.
doi:10.1371/journal.ppat.1002117.g012
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virulence and metabolic genes in pigs and boars with a higher
body temperature (39uC–40uC). In order to test whether the
IS1667 insertion in the invA promoter region and the RovAO:3(S98)
variant reflects an optimal adaptation to these host organisms we
are currently establishing a pig infection model.
Although high levels of invasin are produced by YeO:3 strains
at moderate growth temperatures, cell invasion was either not
initiated or very inefficient when the bacteria were pregrown at
25uC. This is in strong contrast to other Y. enterocolitica serotypes
or Y. pseudotuberculosis isolates which enter host cells with their
highest efficiency when cultured at moderate temperatures.
Previous analyses showed that induced flagellar-dependent
motility is required for efficient invasion of YeO:8, but flagella
production of this pathogen is repressed at 37uC [34]. Flagella are
needed to ensure migration of the bacteria to host cells, but are
not essential for the invasion process once the bacteria contact the
mammalian cells. Motility assays and electron microscopy
revealed that flagellated and motile strains of Y. enterocolitica O:3
strains can be isolated from the intestinal tract of a mouse, but
they rapidly loose their motility and become aflagellated during
growth under standard laboratory conditions. As a result, YeO:3
strains are less invasive than other motile serotypes in vitro,b u tc e l l
entry could be improved upon artificial host cell contact by
centrifugation.
However, when the bacteria were pregrown at 25uC, YeO:3
uptake after host cell contact is still less efficient compared to
YeO:8 or other serotypes, indicating that other factors repress
invasin-mediated internalization at moderate temperatures or
enhance cell entry at 37uC. Y. enterocolitica isolates grown at room
temperature generally express LPS with O-ag, whereas only very
small amounts of O-ag are present in bacteria grown at 37uC
[33,58]. The O-ag of YeO:8 is required for full virulence and plays
a major role in pathogen-host interplay by affecting the expression
Figure 13. Comparison of Y. enterocolitica O:3 and O:8 mediated temperature regulated control of host cell invasion. Model of
virulence factor expression of Y. enterocolitica O:3 and O:8 in response to temperature. (A) At moderate temperature, rovA expression is induced in Y.
enterocolitica O:8 which leads to activation of invasin expression. Furthermore, flagella production is activated and enhances host cell contact, and
LPS molecules are synthesized which do not interfere with invasin function. This leads to an efficient internalization of the serotype O:8 strains after
growth at environmental temperatures. At 37uC, RovA is rapidly degraded resulting in downregulation of invasin. In addition, flagella and O-antigen
production is repressed, whereas synthesis of the adhesin YadA is induced which allows efficient adhesion, but no internalization into epithelial cells.
(B) Y. enterocolitica O:3 produce similar and significantly higher amounts of invasin at environmental and body temperature due to an IS insertion
into the invA upstream region and a stable RovA activator protein both abolishing H-NS mediated repression. However, internalization into host cells
is strongly reduced at 25uC due to steric hindrance by the unique O-antigen and repression of YadA which strongly enhances and stabilizes host cell
interactions at 37uC. LPS+OC: lipopolysaccharides with O-antigen and outer core.
doi:10.1371/journal.ppat.1002117.g013
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O-ag reduced invA expression and internalization into HeLa cells
[31]. In contrast, O-ag deficient YeO:3 rough mutants are more
efficiently internalized by human epithelial cells. Furthermore, no
reduction of invA expression was observed in the rough mutants at
37uC when O-ag expression is fully repressed. Unlike other Yersinia
serotypes and other Gram-negative bacteria, the YeO3 O-ag
forms a long homopolymer that is linked together with the OC
hexasaccharide to the inner core forming a unique branched LPS
structure. Its formation was previously shown to prevent proper
function of some small size outer membrane proteins. For
instance, O-ag was shown to inhibit serum resistance indirectly
by masking the adhesin Ail from complement regulator C4bp
binding [59]. Therefore, reduced O-ag density in YeO:3 at 37uC
is very likely diminishing sterical hindrance thus allowing better
access and host cell receptor binding by surface adhesins such as
invasin and YadA (Fig. 13).
In fact, besides invasin, also production of the adhesin YadA
is required to promote efficient uptake of YeO:3. The
virulence plasmid encoded trimeric YadA protein is highly
and exclusively expressed at 37uC, and forms a capsule-like,
fibrillar matrix covering the bacterial surface [60]. YadA of Y.
enterocolitica O:8 strains has been shown to promote tight
binding to extracellular matrix proteins such as collagen and
laminin, but it does not contribute to epithelial cell entry
compared to invasin [19,61]. In fact, at 37uCw h e nY a d Ai s
highly expressed but no or only very low levels of invasin are
produced by YeO:8, no internalization of the bacteria is
initiated (Fig. 3B, 6A). Internalization of YeO:3 at 37uCa l s o
seems to be exclusively mediated by invasin as an invA mutant
is unable to enter host cells. Yet, YadA synthesis is not
dispensable, as its absence in a yadA mutant or during growth
at 25uC results in a significantly lower cell adhesion and uptake
rate even in the presence of high amounts of invasin, whereas
yadA expression by an inducible promoter at 25uCl e a d st o
strong adhesion and efficient invasion of YeO:3 similar to
YeO:8. YadA seems to be required to guarantee tight and
e f f i c i e n th o s tc e l lb i n d i n gw h i c ht h e ni nt u r nl e a d st oam o r e
efficient invasin-mediated uptake. Both invasin and YadA
promote direct or indirect binding to beta 1 integrins [13,62].
High affinity binding and ligand-induced beta 1-integrin-
clustering by invasin are required for efficient uptake by this
host cell receptor family [63,64]. However, invasin of Y.
enterocolitica does not contain a self-association domain medi-
ating receptor-clustering and uptake in contrast to invasin of Y.
pseudotuberculosis [65]. It is therefore tempting to speculate that
co-expression of the somewhat longer cell surface adhesin
YadA which promotes binding to ECM molecules bound to
beta 1 chain integrins promotes or enhances intimate direct
interaction of invasin and subsequent internalization (Fig. 13).
In summary, results in the present investigation provide
evidence that even small variations between virulence factors
and regulators are responsible for the substantial difference in host
cell interactions of Y. enterocolitica serotype O:3 in comparison to
other Y. enterocolitica serotypes. Serotype O:3 specific variations in
the surface molecule expression pattern imply that this Y.
enterocolitica subspecies varies in its dynamic capacity to adapt to
changing environments and individual niches within the host. A
particular repertoire of host interaction genes may confer a
survival advantage or pathogenic potential in a specific microen-
vironment. Thus, an individual subspecies may be better adapted
for survival in a particular host or host site, e.g. human
gastrointestinal tract or oral cavities of swine (e.g. tongue and
tonsils).
Materials and Methods
Ethics statement
All animal work was performed in strict accordance with the
German regulations of the Society for Laboratory Animal Science
(GV-SOLAS) and the European Health Law of the Federation of
Laboratory Animal Science Associations (FELASA). The protocol
was approved by the Niedersa ¨chsisches Landesamt fu ¨r Verbrau-
cherschutz und Lebensmittelsicherheit: animal licensing commit-
tee permission no. 33.9.42502-04-055/09. All efforts were made
to minimize suffering.
Bacterial strains, cell culture, media and growth
conditions
The strains used in this study are listed in Table 1. Overnight
cultures of E. coli were routinely grown at 37uC, Yersinia strains
were grown at 25uCo r3 7 uC in LB (Luria-Bertani) broth. The
antibiotics used for bacterial selection were as follows: ampicillin
100 mg/ml, chloramphenicol 30 mg/ml, kanamycin 50 mg/ml,
gentamicin 50 mg/ml and tetracycline 10 mg/ml. For infection
experiments, bacteria were grown at 25uCo r3 7 uC, washed and
diluted in PBS prior to infection.
Human HEp-2 cells were cultured in RPMI 1640 media with
GlutaMAX (Invitrogen) supplemented with 7.5% newborn calf
serum (Sigma Aldrich) at 37uC in the presence of 5% CO2.
Human Caco-2 cells were grown in DMEM/HAM’s F-12
(Biochrom) supplemented with 10% FBS Superior (Biochrom).
DNA manipulations and construction of plasmids
All DNA manipulations, PCR, restriction digestions, ligations
and transformations were performed using standard techniques as
described previously [66,67]. Plasmids used in this study are listed
in Table 1, and primers are given in Table S2.
Plasmids pFU49 (invAO:3) and pFU182 (invAO:8) were construct-
ed by amplification of the invA gene from genomic DNA of YeO:3
Y11 and YeO:8 8081v with primers II40/II42 and the PCR-
derived fragments were subsequently integrated into the SacI/SalI
sites of pBAD33. For the overexpession of RovAO:8 the rovA gene
was amplified from genomic DNA of YeO:8 8081v with primers
II417/II418 and the generated fragment was inserted into the
NcoI/XhoI sites of pET28a, generating pFU156. Plasmid pFU157
was obtained by QuikChange mutagenesis of pFU156 using
primer II375/II376. Plasmid pFU199 was constructed by inserting
a hns
+
O:3 fragment amplified with primers II726/II727 into the
EcoRI/SalI sites of pASKIBA43+. For the construction of pFU220
a BamHI/SalI fragment of pFU188 containing the yadA gene was
integrated into pBAD33. pFU188 was obtained by insertion of a
PCR fragment amplified with primers II517/II518 from genomic
DNA of YeO:3 Y11 into the NcoI/SalI sites of pBAD/Myc-HisA.
Plasmids pFU170 and pFU171 encoding the PinvAO:8::luxCDABE
and PinvAO:3::luxCDABE reporter fusions were generated by
insertion of a PCR fragment amplified with primers II177/II178
from genomic DNA of YeO:8 8081v or YeO3 Y11 in the BamHI/
SalI sites of pFU175. To construct plasmid pFU172, carrying the
PinvAO:3 DIS::luxCDABE fusion, two PCR fragments amplified with
primer pairs II177/II179 and II180/II178 were first ligated with
their blunt ends and cloned into the BamHI/SalI sites of luxCDABE
fusion vector pFU175. Plasmids pFU194–198 were constructed to
analyse the effect of promoter PinvAO:3 truncations. This was
accomplished by separate cloning of five DNA fragments
amplified with primers II542–546 and II178 from genomic
DNA of YeO:3 Y11 into the BamHI/SalI sites of pFU175.
Plasmids pFU201 and pFU202 carry the invAO:3 promoter region
from position 2248 to 2146 and from 2448 to 2146,
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Strains, Plasmids Description Source and reference
Bacterial strains
E. coli K-12
DH101beta F
2 endA1 recA1 galE15 galK16 nupG rpsL DlacX74 Invitrogen
w80lacZDM15 araD139 D(ara,leu)7697 mcrA
D(mrr-hsdRMS-mcrBC) l
2
S17-1 lpir Tp
r Sm
r recA, thi, pro, hsdR
2M
+ RP4:2-Tc:Mu:Km Tn7 [73]
lpir
BL21 CodonPlus F
2 ompT hsdS(rB
2mB
2) dcm
+ Tet
r gall (DE3) endA Stratagene
(DE3)-RIL Hte [argU ileY leuW Cam
r] (DE3)- RIL
BL21 lDE3 F
2 ompT gal dcm lon hsdSB(rB
2 mB
2) gal lDE3 [74]
KB4 BL21 lDE3 stpA hns hha Katja Bo ¨hme
Y. enterocolitica
YeO3 6471/76 serotype O:3, patient isolate, wild-type [75]
YeO3-OC 6471/76, D(wzx-wbcQ), outer core negative [42]
derivative of 6471/76
YeO3-OCR spontaneous rough derivative of YeO3-OC [42]
YeO3-R2 spontaneous rough derivative of YeO3 [30]
Ye 8081v bioserotype 1A/O:8, patient isolate, wild-type [15]
4620 bioserotype 3/O:9, patient isolate, wild-type A. Fruth
3056 bioserotype 3/O:5,27, patient isolate, wild-type A. Fruth
Y11 bioserotype 4/O:3, patient isolate, wild-type A. Rakin
Y1 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y2 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y3 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y4 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y5 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y8 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y32 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y33 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
Y34 bioserotype 4/O:3, patient isolate, wild-type E. Strauch
YE01 Y11, DrovA,C m
R This study
YE12 Y1, DrovA,C m
R This study
YE13 YE12, ProvAO:3::rovAS98,C m
R Kn
R This study
YE14 YE12, ProvAO:3::rovAP98,C m
R Kn
R This study
YE15 Y1, PinvADIS1667 This study
YE18 Y1, DyadA, Tet
R This study
YE21 Y1, DinvA,K n
R This study
Plasmids
pASKIBA43+ overexpression vector, Ap
R IBA
pBAD33 overexpression vector, Cm
R [76]
pBADmycA-HisA overexpression vector, Ap
R Invitrogen
pET28a overexpression vector, Kn
R Novagen
pFU32 ColE1, promoterless luc, Tet
R lab collection
pFU49 pBAD33, invA
+
O:3,C m
R This study
pFU99 pSC101*, promoterless lacZ,C m
R lab collection
pFU100 R6K, mobRP4, promoterless luxCDABE,C m
R lab collection
pFU102 pFU100, rovA::Cm
R This study
pFU109 pSC101*, promoterless lacZ,K n
R lab collection
pFU114 pFU100, ‘invA’ (nt 40–339), Cm
R This study
pFU119 pFU109, ProvAO:3::rovAO:3,K n
R This study
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PCR fragments were amplified with primer pairs II570/II543 and
II571/II543, respectively, and integrated into the BamHI/SalI sites
of pFU175. The ProvA::lacZ fusions plasmids pFU129 and pFU130
were constructed by insertion of rovA promoter fragments,
amplified with primer pair II260/I277 from genomic DNA of
YeO:8 strain 8081v or YeO:3 strain Y11, into the BamHI/SalI
sites of pFU109.
Following plasmids were engineered for the construction of rovA,
invA and yadA mutant strains of Y. enterocolitica. For rovA
mutagenesis, plasmid pFU167 was constructed by amplification
of sacB with primers II421/II422 from pJE4 and integration into
the AvrII/NotI sites of pFU102. pFU102 was constructed by
insertion of three PCR-derived fragments into the SpeI/NotI sites of
pFU100: (i) a SpeI/SacI fragment containing 179 bp of the rovA
regulatory region amplified with primers II171/II172, (ii) a SacI/
AatII fragment encoding the chloramphenicol resistance gene of
pZA31 luc, and (iii) a AatII/NotI containing 119 bp of the
downstream region of rovA amplified with primers II173/II174.
For the invA mutagenesis, plasmid pFU213 was constructed by
insertion of the SacI/AatII fragment encoding the kanamycin
resistance gene of pZS*24MCS into pFU114. The plasmid
pFU114 was constructed by insertion of an ‘invA’ fragment into
the SalI/NotI sites of pFU100. The PCR fragment contained base
pairs 40–339 of the invA coding region, amplified from genomic
DNA of YeO:3 Y11 with primer pairs II211/II212 which
introduce stop codons at the 59 and 39 end in the open reading
frame of the ‘invA’ fragment. For yadA mutagenesis, plasmid
pFU187 was used. This plasmid was engineered by the insertion of
three PCR fragments into the SpeI/NotI sites of pFU167: (i) a SpeI/
SacI fragment which contained 150 bp of the yadA regulatory
region amplified from genomic DNA of YeO:3 Y11 with primer
pair II513/II514 (ii) a SacI/AatII fragment of pFU32 encoding the
tetracycline resistance gene, (iii) and a AatII/NotI fragment
containing the last 81 bp of the yadA gene plus 69 bp of the yadA
downstream region amplified from genomic DNA of YeO:3 Y11
with primer pair II515/II516.
For deletion of the IS1667 element in the invAO:3 regulatory
region, we used pFU190. Plasmid pFU190 was created by the
insertion of three fragments. Two fragments starting from position
21887 to 21627 and 2249 to 21 of the invA promoter region
were amplified with primer pairs II519/II522 and II523/II524,
respectively, and ligated at their blunt ends. The resulting XhoI/
NotI fragment was ligated with the SpeI/XhoI fragment from
Strains, Plasmids Description Source and reference
pFU129 pFU109, ProvAO:8::lacZ,K n
R This study
pFU130 pFU109, ProvAO:3::lacZ,K n
R This study
pFU138 pFU119, ProvAO:3::rovAO:8,K n
R This study
pFU156 pET28a, rovA
+
O:8,K n
R This study
pFU157 pET28a, rovA
+
O:3,K n
R This study
pFU167 pFU102, rovA::Cm
R, sacB This study
pFU170 pSC101*, PinvO:8::luxCDABE,K n
R This study
pFU171 pSC101*, PinvO:3::luxCDABE,K n
R This study
pFU172 pSC101*, PinvO:3DIS::luxCDABE,K n
R This study
pFU175 pSC101*, promoterless luxCDABE,K n
R lab collection
pFU182 pBAD33, invA
+
O:8,C m
R This study
pFU184 pFU119, ProvAO:3::rovAO:3,K n
R This study
pFU185 pFU138, ProvAO:3::rovAS98P,K n
R This study
pFU187 pFU167, yadA::Tet
R This study
pFU188 pBADmycA-HisA, yadA
+
O:3,A p
R This study
pFU190 pFU167 PinvAO:3 (21887 to 21627/2249 to 21), Tet
R This study
pFU194 pFU175, 21169 bp invA upstream region, Kn
R This study
pFU195 pFU175, 2448 bp invA upstream region, Kn
R This study
pFU196 pFU175, 2248 bp invA upstream region, Kn
R This study
pFU197 pFU175, 2146 bp invA upstream region, Kn
R This study
pFU198 pFU175, 272 bp invA upstream region, Kn
R This study
pFU199 pASKIBA43+, hns
+
O:3,A p
R This study
pFU201 pSC101*, PinvO:3(2248 to 2146)-luxCDABE,K n
R This study
pFU202 pSC101*, PinvO:3(2448 to 2146)-luxCDABE,K n
R This study
pFU213 pFU114, ‘invA’ (nt 40–339), Kn
R This study
pFU220 pBAD33, yadA
+
O:3,C m
R This study
pJE4 R6K, sacB
+,K n
R J. Eitel
pZA31luc expression vector, p15A, PLtetO-1,C m
R [77]
pZS*24MCS expression vector, pSC101*, Plac/ara-1,K n
R [77]
doi:10.1371/journal.ppat.1002117.t001
Table 1. Cont.
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inserted into the SpeI/NotI sites of pFU167.
Plasmids pFU184 and pFU185 were used for chromosomal
integration of a rovA wild-type and a rovAS98P mutant copy. Both
plasmids were constructed by insertion of the SacI/AvrII fragment
harboring the R6K ori and the mobRP4 mobilization region from
pFU100 into pFU119 and pFU138, respectively. For the
generation of pFU119 rovAO:3 including its regulatory region was
amplificated from genomic DNA of YeO:3 strain Y11 with primer
pair II260/II226 and cloned into the BamHI/NotI sites of pFU109.
pFU138 was obtained by QuikChange mutagenesis (Stratagene) of
pFU119 using primer II377/II378. All clones were confirmed by
sequencing (GATC, Konstanz, Germany).
Construction Y. enterocolitica mutant strains
To construct the rovA, invA, and yadA mutants, the suicide
plasmids carrying an internal fragment of invA with integrated stop
codons (pFU213), or the insertion mutations rovA::Cm
R (pFU167)
or yadA::Tet
R (pFU187) were propagated in E. coli S17-1 lpir and
introduced by mobilization into YeO:3 strain Y1 and Y11.
Transconjugants were selected on Yersinia selective agar (Oxoid)
supplemented with antibiotics, selecting for the resistance of the
plasmids. Since the suicide vectors cannot replicate in the YeO:3
strains, the obtained colonies are the result of plasmid integration
into the Yersinia chromosome at regions of homology. The
recombination event yielded merodiploid strains, which includes
a wild-type and a mutant copy. Spontaneous second site
recombinants where the integrated suicide vector and the wild-
type copy of the gene were eliminated were isolated by selecting
fast growing transconjugants on 10% sucrose plates. The rovA gene
of YeO:3 (rovAO:3) and YeO:8 (rovAO:8) were introduced into the
DrovA strain YE12 by conjugation. Loss of the gene function in
resulting mutant strains YE1 (DrovA), YE12 (DrovA), YE18 (DyadA)
and YE21 (DinvA) and regain of RovA production in strains YE13
(rovAO:3) and YE14 (rovAO:8) was verified by PCR and western
blotting analysis. Deletion of the IS1667 element in PinvAO:3 was
achieved by conjugation of plasmid pFU190 into YeO:3 strain Y1
as described above. All deletions and reintegration were verified by
PCR.
Quantitative real-time PCR
Quantitative RT-PCR was performed in triplicate with
independent RNA preparations using a Rotor-Gene Q thermo
cycler (Qiagen). RNA was prepared using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s protocol. 1 mg total
RNA was taken for cDNA synthesis using the QuantiTect Reverse
Transcription Kit (Qiagen) according to the manufacturer’s
instructions. For quantitative RT-PCR, reagents from Qiagen
QuantiTect SYBR Green PCR KIT (Qiagen) were used. Gene
specific-primers used for qRT-PCR amplification are listed in
Table S2 and were designed to produce a 120–150 bp amplicon.
The amount of PCR product was quantified by measuring
fluorescence of SYBR Green dye. Reported gene expression levels
were normalized to levels of the 5S rRNA. Standard curves were
detected during every run for each gene tested and established by
comparing transcript levels in serial dilutions of total RNA from a
control sample.
Primer extension analysis to determine the
transcriptional start sites of the invA and the IS1667-
specific promoter
Primer extension analysis was performed to determine the
transcription start points of the invA gene in strain Y1. Y.
enterocolitica Y1 was grown in LB at 25uCt oa nO D 600 of 3.0
(stationary phase). Total RNA was extracted of the samples using
the SV total RNA purification kit (Promega) as described by the
manufacturer. Annealing was performed with 20 mg extracted
RNA and the 59-Dig-labelled oligonucleotides (primer III94 for
the IS1667 specific promoter, primer III91 for the invA promoter)
in 20 mlo f1 6First Strand Buffer (Invitrogen) by slow cooling of
the sample (0.01uC/sec) including 8 mM dNTPs and 56 FS
Buffer (Invitrogen). 200 U Superscript II reverse transcriptase
(Invitrogen) was added and incubated for 1 h at 42uC. The size of
the Dig-labelled reaction products was determined on a denatur-
ing 4% DNA sequencing gel by a detection procedure as described
[68].
Luciferase and beta-galactosidase assays
Optical density (OD600) of three independent cultures of the
bacteria harboring the different luciferase reporter plasmids was
determined and diluted to an OD600 of 0.1 to monitor growth of
the bacteria at indicated growth conditions (complex media, 25uC
and 37uC). In parallel, bioluminescence was detected in non-
permeabilized cells with a Varioskan Flash (Thermo Scientific)
using the SkanIt software (Thermo Scientific). Bioluminescence
was measured for 1 s every 30 min and is given as relative light
units (RLU/OD600) from three independent cultures performed in
duplicate. Beta-galactosidase activity was determined as described
[44]. The activities were calculated as follows: beta-galactosidase
activity OD420 N 6.75 OD600
21 N Dt (min)
21 N vol (ml)
21.
Purification of Y. enterocolitica RovA and H-NS
RovA proteins were overexpressed in E. coli BL21 CodonPlus
(DE3)-RIL, H-NS was expressed in E. coli KB4. Overnight
cultures of E. coli strains, harbouring the plasmids pFU156
(rovAO:8-his6), pFU157 (rovAO:3-his6) or pFU199 (his6-hns) were
diluted 1:100 and grown at 37uC in LB medium for 2 h.
Subsequently, protein synthesis was induced with 100 mM IPTG
(pFU156, pFU157) or 200 mg/l AHT (pFU199) and grown for
4 h. Bacteria overexpressing His-tagged RovA proteins were
purified as described [55].
Gel electrophoresis, preparation of cell extracts and
western blotting
For the analysis of invA and rovA expression bacteria were grown
under environmental conditions as described. The optical density
of the cultures was adjusted and a 1 ml aliquot was withdrawn
from each culture. The cells were collected by centrifugation, and
resuspended in 100 ml sample buffer (100 mM Tris-HCl pH 6,8,
2% SDS, 10% glycerol, 3% DTT, 0.001% bromophenol blue) and
analyzed by gel electrophoresis and western blotting. For the
immunological detection of the InvA, YadA and RovA proteins,
the cell extracts were separated on 10% or 15% SDS-
polyacrylamide gels, and the proteins were separated by
electrophoresis and transferred onto an Immobilon membrane
(Millipore). Identity and expression of the adhesins were confirmed
by westernblotting analysis using polyclonal antibodies against the
Y. enterocolitica invasin or the Y. pseudotuberculosis RovA and YadA
protein, and a second goat alkaline-phosphate antibody (Sigma)
using 5-bromo-4-chloro-3-indoylphosphate (XP) and nitroblue
tetrazolium (Boehringer Mannheim) as substrates.
In vivo stability analysis of RovA
Protein biosynthesis of bacterial cultures in exponential phase at
37uC was stopped by adding 50 mg/ml gentamycin and 50 mg/ml
tetracycline. Samples were taken at indicated time points.
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Binding of RovA to defined PCR fragments carrying different
portions of the invA regulatory region was carried out in a 20 ml
reaction mixture containing increasing amounts of purified RovA
protein (0.5–1.5 mg) and 80 ng of DNA. The reaction buffer
contained 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM
NaCl, 5 mM MgCl2, 5 mM dithiothreitol (DTT) and 5% glycerol.
The reaction mixture was incubated for 20 min at room
temperature or at 37uC and separated on polyacrylamide gels as
described [44]. PCR fragments encoding the invA promoter
fragments a, b and c were amplified with primer pairs II519/
II551, II546/II178 and II558/II559, and the csiD promoter
fragment was produced by PCR with primer pairs 131/132.
Motility assays
A2ml aliquot of an overnight culture grown at 25uCi nL B
medium was spotted onto semisolid agar plates containing 0.35%
agar to evaluate motility [69]. The capacity of YeO:3 Y1 and
YeO:8 8081v to spread was monitored after 48 h at 25uC and
37uC.
Electron microscopy
YeO3 Y1 and YeO8 8081v grown at 25uC and 37uC overnight
were fixed in growth medium with 1% formaldehyde. For
transmission electron microscopy thin carbon support films were
prepared by sublimation of carbon on freshly cleaved mica. Using
300 mesh copper grids, the samples were negatively stained with
2% (w/v) aqueous uranylacetate, according to the method of [70],
and examined in a transmission electron microscope (TEM910,
Zeiss, Germany) at an acceleration voltage of 80 kV at calibrated
magnifications. Images were recorded digitally with a Slow-Scan
CCD camera (ProScan 102461024, Scheuring, Germany) with
ITEM software (Olympus Soft Imaging Solutions, Mu ¨nster,
Germany). Images were corrected for brightness and contrast
applying Adobe photoshop CS3.
For field emission scanning electron microscopy glass coverslips
samples were fixed with a solution containing 5% formaldehyde
and 2% glutaraldyhde in cacodylate buffer (0.1 M cacodylate,
0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose pH 6.9). Dehy-
dration was carried out in a graded series of acetone (10%, 30%,
50%, 70%, 90%, 100%) on ice for 15 min for each step. Samples
were then critical-point dried with liquid CO2 (CPD 030, Balzers
Union, Liechtenstein) and covered with a gold film by sputter
coating (SCD 040, Balzers Union, Liechtenstein). For examination
in a field emission scanning electron microscope (DSM 982
Gemini, Zeiss, Germany), an Everhart Thornley SE detector was
used with the inlens SE detector in a 50:50 ratio at an acceleration
voltage of 5 kV.
Cell adhesion and invasion assay
For cell adhesion and uptake assay 5610
4 HEp-2 cells were
seeded and grown overnight in individual wells of 24-well cell
culture plates. Cell monolayers were washed three times with PBS
and incubated in binding buffer (RPMI 1640 medium supple-
mented with 20 mM HEPES (pH 7.0) and 0.4% BSA before the
addition of bacteria. Approximately 5610
5 bacteria were added to
the monolayer and incubated without or after centrifugation of the
bacteria onto the monolayer at 22–25uC to prevent bacterial
internalization and 37uC to test for cell binding and invasion as
described [62,71]. 30 min post infection, the cells were washed
extensively with PBS. The total number of host cell-associated
bacteria was determined by cell lysis using 0.1% Triton X-100 and
plating on bacterial media. Bacterial uptake was assessed 30 min
after infection as the percentage of bacteria, which survived killing
by gentamicin, as described [63]. For each strain, the relative level
of bacterial adhesion and uptake was determined by calculating
the number of colony-forming units relative to the total number of
bacteria introduced onto monolayers. Number of invaded bacteria
is given relative to the number of cell-bound bacteria. The
experiments were routinely performed in triplicate.
Mouse infection
Bacteria used for oral infection were grown overnight in LB
medium at 25uC, washed and resuspended in PBS. Female
BALB/c mice 6–8 weeks old were purchased by Janvier. Groups
of 7–10 animals were pretreated with desferal 24 h prior infection
as described previously [72]. Subsequently, mice were orally
infected with Y. enterocolitica strains Y1, YE15 or YE14 in single
infection and co-infection experiments using a ball-tipped feeding
needle. 5610
8 bacteria of each strain were administered
orogastrically. In co-infection experiments, mice were orally
infected with an equal mixture of 5610
7 (low dose) or 5610
8
(high dose) bacteria of Y. enterocolitica strains Y1 and YE14, or Y1
and YE15. For discrimination of strains Y1 and YE15 low-copy
vectors pFU99 and pFU109 with different antibiotic resistance
cassettes were introduced in Y1 and Y15, respectively. Presence of
these vectors had no effect on Yersinia fitness and virulence and
they were maintained in all bacteria recovered from host tissues
throughout a five days time course of infection (F. Uliczka,
unpublished results). Three or five days after infection, mice were
euthanized by CO2. Peyer’s patches, mesenteric lymph nodes,
liver and spleen were isolated. The ileum was rinsed with sterile
PBS and incubated with 100 mg/ml gentamicin in order to kill
bacteria on the luminal surface. After 30 min, gentamicin was
removed by extensive washing with PBS for three times.
Subsequently, all organs were weighed and homogenized in sterile
PBS at 30.000 rpm for 30 sec using a Polytron PT 2100
homogenizer (Kinematica, Switzerland). The numbers of bacteria
were determined by plating three independent serial dilutions of
the homogenates on LB plates with and without antibiotics. The
colony forming units (cfu) were counted and are given as cfu per g
organ/tissue. The competitive index relative to wild-type strain Y1
was calculated as described by Monk et al. 2008 [78].
Supporting Information
Figure S1 Y. enterocolitica O:3 interaction with epithe-
lial cells. Ten different Y. enterocolitica serotype O:3 isolates from
human patients or pigs, Y. enterocolitica O:8 strain 8081v, Y.
enterocolitica O:9 strain 4620 and Y. enterocolitica O:5,27 strain 3056
were grown at 25uC overnight in LB medium. About 5?10
4 HEp-2
cells were infected with 5?10
5 bacteria and incubated at 37uCt o
determine cell association (adhesion+invasion) and the internali-
zation efficiency of the bacteria. E. coli K-12 was used as negative
control. Data are presented as means 6 standard deviations of
three independent experiments performed in duplicate.
(EPS)
Figure S2 Motility of YeO:3 within the intestinal tract of
infected Balb/c mice. Transmission electron microscopy of Y.
enterocolitica O:3 strain Y1 isolated from the intestine of Balb/c
mice three days after infection.
(EPS)
Figure S3 Quantitative RT-PCR of invA expression.
Quantitative RT-PCR was performed on total RNA extracted
from the Y. enterocolitica wild-type strain Y1, the isogenic rovA
deletion mutant (YE12), the reconstituted rovA
+ strain (YE13), and
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growth phase. All values are expressed as relative mRNA levels
compared to expression levels of the wild-type Y1. The calculated
ratios in the relative invA expression levels between wild-type and
the rovA or the IS1667 deletion mutant determined by quantitative
RT-PCR and invA-lux fusions are given below the graph.
(EPS)
Figure S4 Mapping of the transcriptional start sites by
primer extension analysis. Twenty mg of total RNA isolated
of Y. enterocolitica O:3 strain Y1 grown at 25uC were used as
template RNA with primers specific for the invA regulatory region.
The sequencing ladders are shown on the left. The arrows mark
the +1 transcriptional start sites within the IS1667 element (A) and
the invA promoter region (B). The putative 210 region is given in
bold letters.
(EPS)
Figure S5 Interaction of RovAO:3(S98) and RovAO:8(P98)
with the invA regulatory region at 256C and 376C. (A)
Overview of the invA promoter region of Y. enterocolitica O:3 strains.
The transcriptional start sites of the invA promoter and of the
predicted IS1667-encoded promoter are indicated by broken
arrows. The dark boxes represent the RovA and the white small
boxes the H-NS binding sites identified in the homologous invA
promoter of Y. pseudotuberculosis [46]. The thick line represents the
invA promoter sequence and the thin line illustrates the sequence of
the IS1667 element with the putative transposase gene. The
fragment used for the band shift experiments is shown by a black
line. (B) The double-stranded promoter fragment of the invA
regulatory region harbouring one RovA-binding site was incubated
without or with increasing concentrations of purified RovAO:3(S98)
or RovAO:8(P98) at 25uCa n d3 7 uC. The DNA-protein complexes
were separated on a 4% polyacrylamide gel. A non-specific probe
containing weight standard 100 bp ladder was loaded on the left.
The higher molecular weight protein-DNA complexes and the
positions of the non-shifted control fragments are indicated.
(EPS)
Figure S6 Analysis of RovA expression in Y. enterocoli-
tica O:3. Y. enterocolitica strains YeO:8 8081v, YeO3, Y11 and an
isogenic rovA mutant of Y11 (YE01) harboring the fusion plasmid
ProvAO:8::lacZ or ProvAO:3::lacZ were grown at 25uC and 37uC
overnight. The beta-galactosidase activity determined from the
cultures is given in mmol min
21 mg
21 and represents the mean 6
standard deviation of at least three independent experiments.
(EPS)
Table S1 Y. enterocolitica O:3 isolates. * date of first
citation found in literature/isolation before indicated time point.
#Analysis of the recently sequenced genomes of twenty Y.
enterocolitica O:3 strains isolated in Great Britain between 1999
and 2002 revealed that all of them contained an IS1667 insertion
at position 2143 with respect to the start codon of the invA gene
and the rovAS98 allele (Alan McNally, personal communication).
(DOC)
Table S2 Primers. Restriction sites used for cloning proce-
dures are underlined.
(DOC)
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